ContractSupplemental Indenture • October 2nd, 2009 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 2nd, 2009 Company Industry JurisdictionTHIS SUPPLEMENTAL INDENTURE, dated as of September 30, 2009 (this “Supplemental Indenture”), is by and among CuraGen Corporation (the “Company”), Celldex Therapeutics, Inc. (“Parent”) and The Bank of New York Mellon (formerly, The Bank of New York), as trustee under the indenture referred to below (the “Trustee”).